The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asn Inc Regulatory News (AAIF)

Share Price Information for Abrdn Asn Inc (AAIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 210.00
Ask: 216.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.857%)
Open: 211.00
High: 0.00
Low: 0.00
Prev. Close: 211.00
AAIF Live PriceLast checked at -
abrdn Asian Income is an Investment Trust

To provide investors with a total return primarily through investing in Asia Pacific securities, including those with an above average yield. The Company aims to grow its dividends over time.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Mgmt. Fee & Reinvestment of Fees by Manager

4 Mar 2024 11:24

RNS Number : 4787F
abrdn Asian Income Fund Limited
04 March 2024
 

abrdn Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

4 March 2024

 

New Management Fee and Reinvestment of Fees by the Manager

 

The Company's Board of Directors is delighted to announce a successful negotiation resulting in a reduction of the management fee the Company pays to abrdn, effective from the beginning of the current financial year starting January 1, 2024. The new fee structure will be determined by the lower of the Company's market capitalisation or net asset value, a change aimed at better aligning the fee with shareholders' interests. The fee will be calculated monthly at a rate of 0.75% per annum on market capitalisation (or net assets, whichever is lower) up to £300 million, and 0.60% for amounts exceeding this threshold. This adjustment is anticipated to decrease the Company's overall ongoing charges for the financial year ending December 31, 2024, by approximately 17% compared to the previous year. Detailed information regarding the Company's ongoing charges for the year ending December 31, 2023, will be provided with the announcement of the Company's financial results expected by the end of March.Furthermore, we are pleased to announce that abrdn has initiated its reinvestment of management fees program by subscribing to 190,000 shares of the Company as of today's date, equivalent to approximately three months' worth of management fees.Ian Cadby, Chairman, commented:"Amid these challenging times for the investment company industry, we find it gratifying to report a meaningful reduction in overall costs for our shareholders in the upcoming year. We also commend our manager for demonstrating its support for the Company through the reinvestment of management fees program, reaffirming its commitment to reinvest a portion of the fees back into the Company."

 

 

abrdn Investments Limited

Administrator

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFLVSISIIS
Date   Source Headline
10th Apr 202412:53 pmRNSNet Asset Value(s)
10th Apr 202411:38 amRNSDoc re. Annual Report
9th Apr 20245:19 pmRNSTransaction in Own Shares
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20242:23 pmRNSInvestor Presentation-10am, Tuesday 30 April 2024
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 20245:11 pmRNSTransaction in Own Shares
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20245:11 pmRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSQuarterly disclosure
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20245:19 pmRNSTransaction in Own Shares
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:15 amRNSTotal Voting Rights
28th Mar 20245:36 pmRNSTransaction in Own Shares
28th Mar 20242:04 pmRNSNet Asset Value(s)
27th Mar 20245:18 pmRNSTransaction in Own Shares
27th Mar 202412:19 pmRNSNet Asset Value(s)
27th Mar 20247:00 amRNSAnnual Financial Report
26th Mar 202412:24 pmRNSNet Asset Value(s)
25th Mar 20245:26 pmRNSTransaction in Own Shares
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20245:14 pmRNSTransaction in Own Shares
22nd Mar 202412:16 pmRNSNet Asset Value(s)
21st Mar 20245:11 pmRNSTransaction in Own Shares
21st Mar 20241:17 pmRNSNet Asset Value(s)
20th Mar 20245:01 pmRNSTransaction in Own Shares
20th Mar 202411:45 amRNSNet Asset Value(s)
19th Mar 202412:24 pmRNSNet Asset Value(s)
18th Mar 20242:19 pmRNSGearing Disclosure
18th Mar 202411:46 amRNSNet Asset Value(s)
15th Mar 20245:13 pmRNSTransaction in Own Shares
15th Mar 202412:22 pmRNSNet Asset Value(s)
14th Mar 20245:07 pmRNSTransaction in Own Shares
14th Mar 20243:46 pmRNSPortfolio disclosure
14th Mar 202411:39 amRNSNet Asset Value(s)
13th Mar 20245:14 pmRNSTransaction in Own Shares
13th Mar 202411:34 amRNSNet Asset Value(s)
12th Mar 20245:19 pmRNSTransaction in Own Shares
12th Mar 202412:20 pmRNSNet Asset Value(s)
11th Mar 20245:07 pmRNSTransaction in Own Shares
11th Mar 20242:27 pmRNSGearing disclosure
11th Mar 202412:28 pmRNSNet Asset Value(s)
8th Mar 20245:26 pmRNSTransaction in Own Shares
8th Mar 202412:36 pmRNSNet Asset Value(s)
7th Mar 20245:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.